https://www.selleckchem.com/pr....oducts/Flavopiridol.
To explore patients' preferred treatment outcomes during their first two years with rheumatoid arthritis (RA). A qualitative, longitudinal, multicenter study with interviews at two time points was performed in Sweden. Individual interviews were conducted at time point 1 with 31 patients with RA, defined as disease duration of ≤1 year and treatment for 3-7 months. Seven focus group interviews and five individual interviews were conducted at time point 2 with 22 patients 12-20 months after treatment initiation. The interviews were an
Like
Comment
Share
